Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage (Q41707535)

7 October 2017

title

Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage (English)

1 reference

7 October 2017

1 reference

5

Chas DeBolt

1 reference

7 October 2017

1

Stacey W Martin

1 reference

7 October 2017

16

Pamela K Cassiday

1 reference

7 October 2017

18

Thomas A Clark

1 reference

7 October 2017

14

Tami H Skoff

1 reference

7 October 2017

2

Lucia Pawloski

1 reference

7 October 2017

13

Adria Lee

1 reference

7 October 2017

10

Kathy Kudish

1 reference

7 October 2017

12

David Selvage

1 reference

7 October 2017

Margaret Williams

3

1 reference

7 October 2017

Keeley Weening

4

1 reference

7 October 2017

Xuan Qin

6

1 reference

7 October 2017

Laura Reynolds

7

1 reference

7 October 2017

Cynthia Kenyon

8

1 reference

7 October 2017

Gregory Giambrone

9

1 reference

7 October 2017

Lisa Miller

11

1 reference

7 October 2017

Hajime Kamiya

15

1 reference

7 October 2017

Maria L Tondella

17

1 reference

7 October 2017

language of work or name

English

0 references

publication date

9 October 2014

1 reference

Clinical Infectious Diseases

7 October 2017

published in

1 reference

7 October 2017

volume

60

1 reference

7 October 2017

issue

2

1 reference

7 October 2017

page(s)

223-227

1 reference

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Waning immunity to pertussis following 5 doses of DTaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Pertactin-negative variants of Bordetella pertussis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Priming with whole-cell versus acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Pertussis pathogenesis--what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Acellular pertussis vaccines and the role of pertactin and fimbriae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Systematic review of the effects of pertussis vaccines in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU788

21 January 2018

Identifiers

DOI

10.1093/CID/CIU788

1 reference

7 October 2017

1 reference